1.63
-0.05 (-2.98%)
-0.05 (-2.98%)
Upgrade to Real-Time
Afterhours (Closed)
Low
1.00
High
3.35
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Kintara Therapeutics Inc | KTRA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.05 | -2.98% | 1.63 | 19:07:50 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.65 | 1.6001 | 1.68 | 1.63 | 1.68 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 1.58 | 1.63 | 0.05 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 786 | 293,771 | $ 1.63 | $ 480,144 | - | 1.00 - 3.35 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:39:24 | 4 | $ 1.58 | USD |
Period:
Draw Mode:
Kintara Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 53.17M | 32.62M | 32.04M | $ - | $ - | -0.88 | -0.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 66.74k | 5.60% |
Kintara Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KTRA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.62 | 1.71 | 1.53 | 1.63 | 203,279 | 0.01 | 0.62% |
| 1 Month | 2.45 | 2.85 | 1.53 | 2.17 | 1,704,785 | -0.82 | -33.47% |
| 3 Months | 1.35 | 2.85 | 1.24 | 1.93 | 1,388,613 | 0.28 | 20.74% |
| 6 Months | 1.90 | 3.35 | 1.24 | 2.06 | 1,152,954 | -0.27 | -14.21% |
| 1 Year | 1.21 | 3.35 | 1.00 | 1.92 | 836,561 | 0.42 | 34.71% |
| 3 Years | 1.21 | 3.35 | 1.00 | 1.92 | 836,561 | 0.42 | 34.71% |
| 5 Years | 1.21 | 3.35 | 1.00 | 1.92 | 836,561 | 0.42 | 34.71% |
Kintara Therapeutics Description
| Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and REM-001 for CMBC. VAL-083 is a small-molecule chemotherapeutic with a novel mechanism of action that has demonstrated clinical activity against a range of cancers, including central nervous system, ovarian, and other solid tumors. The company is also advancing its proprietary late stage photodynamic therapy (PDT) platform that holds promise as a localized cutaneous or visceral tumor treatment as well as in other potential indications. |
